Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 8.3 - Pfizer Inc

20 Nov 2015 15:07

RNS Number : 5016G
Northern Trust Corporation
20 November 2015
 



 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

Northern Trust Group

Company dealt in

Pfizer Inc

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary Shares

Date of dealing

19th November 2015

 

2. INTERESTS AND SHORT POSITIONS*

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

 86,598,424 1.40

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 86,598,424 1.40

 

* Note: The difference in holdings from yesterday and today not explained by transactions, can be explained by stock transfers of 48,473 securities into the relevant accounts

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

 

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

Total

 

 

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (USD)

Buy

200

32.05

Buy

455

32.24

Buy

283

32.28

Buy

547

32.29

Sell

587

32.16

Sell

1078

32.23

Sell

3844

32.25

Sell

529

32.26

Sell

1814

32.28

Sell

2568

32.29

Buy

200

32.18

 

Sell

100

32.06

Sell

100

32.14

Sell

1500

32.24

Sell

900

32.30

Sell

320

32.39

Sell

225

32.42

Sell

24800

32.90

Buy

658

32.27

Buy

12

32.36

Buy

37

32.40

Buy

274

32.50

Sell

10

32.02

Sell

38

32.09

Sell

2544

32.12

Sell

5

32.15

Sell

226

32.19

Sell

22

32.20

Sell

280

32.22

Sell

228

32.28

Sell

240

32.34

Sell

3

32.35

Sell

6

32.36

Sell

48

32.43

Sell

5

32.57

Sell

11

32.81

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

N/A

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  NO

 

Date of disclosure

 20th November 2015

Contact name

Paul Adair

Telephone number

020 7982 1236

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEBMBATMBMTBIA
Date   Source Headline
19th May 201412:59 pmRNSForm 8.3 - AstraZeneca Plc
19th May 201412:53 pmRNSForm 8.3 - Pfizer Inc
19th May 201412:50 pmRNSForm 8.3 - Pfizer Inc
19th May 201412:24 pmRNSForm 8.5 (EPT/NON-RI) Replacement
19th May 201412:19 pmRNSForm 8.5 (EPT/RI)
19th May 201412:04 pmRNSForm 8.3 - Pfizer Inc
19th May 201411:32 amRNSForm 8.5 (EPT/NON-RI)
19th May 201411:19 amRNSForm 8.5 (EPT/RI)
19th May 201411:18 amRNSForm 8 (DD) - [Pfizer Inc]
19th May 201411:16 amBUSForm 8.3 - Pfizer Inc
19th May 201411:12 amRNSForm 8.5 (EPT/RI) Pfizer Inc
19th May 201411:10 amRNSForm 8.5 (EPT/RI) Pfizer Inc
19th May 201411:09 amRNSForm 8.5 (EPT/RI) Pfizer Inc
19th May 201410:50 amRNSForm 8.5 (EPT/RI) - Pfizer
19th May 20149:22 amRNSRule 2.10 Announcement
19th May 20147:08 amRNSASTRAZENECA BOARD REJECTS PFIZER'S FINAL PROPOSAL
19th May 20147:00 amRNSPFIZER MAKES FINAL PROPOSAL TO ASTRAZENECA
19th May 20147:00 amPRNForm 8.3 - Pfizer Inc.
16th May 20145:00 pmRNSForm 8.3 - Replacement Pfizer Inc
16th May 20144:59 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
16th May 20144:57 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
16th May 20144:33 pmRNSForm 8 (DD) - Pfizer Inc.
16th May 20144:27 pmRNSForm 8.5 (EPT/NON-RI)Amendment
16th May 20144:19 pmRNSForm 8.5 (EPT/NON-RI)
16th May 20143:39 pmRNSForm 8 (DD) - [Pfizer Inc]
16th May 20143:39 pmRNSForm 8 (DD) - [Pfizer Inc] - Amendment
16th May 20143:34 pmRNSForm 8.3 - Pfizer Inc
16th May 20143:12 pmBUSForm 8.3 - Pfizer Inc
16th May 20143:03 pmRNSForm 8.3 - Pfizer Inc.
16th May 20142:57 pmRNSForm 8.3 - [PFIZER INC]
16th May 20142:39 pmRNSForm 8.3 - Pfizer Inc
16th May 20142:39 pmRNSForm 8.3 - Pfizer Inc.
16th May 20142:38 pmBUSForm 8.3 - Pfizer Inc.
16th May 20142:33 pmBUSForm 8.3 - Pfizer Inc
16th May 20142:32 pmRNSForm 8.3 - [AstraZeneca Plc]
16th May 20142:31 pmRNSForm 8.3 - [Pfizer Inc]
16th May 20141:53 pmBUSForm 8.3 - Pfizer Inc.
16th May 20141:34 pmRNSForm 8.3 - Pfizer Inc
16th May 201412:57 pmBUSForm 8.3 - Pfizer Inc
16th May 201412:33 pmRNSForm 8.3 - [Pfizer Inc]
16th May 201412:32 pmRNSForm 8.5 (EPT/RI)AMENDMENTS
16th May 201412:27 pmRNSForm 8.3 - Pfizer Inc
16th May 201412:26 pmRNSForm 8.3 - Pfizer Inc
16th May 201412:24 pmRNSForm 8.3 - AstraZeneca Plc
16th May 201412:24 pmRNSForm 8.3 - AstraZeneca Plc
16th May 201412:01 pmRNSForm 8.3 - [Pfizer/Astrazeneca]
16th May 201411:55 amRNSForm 8.3 - Pfizer Inc
16th May 201411:54 amRNSForm 8.5 (EPT/RI) - Pfizer Inc.
16th May 201411:40 amRNSForm 8.5 (EPT/RI) Pfizer Inc
16th May 201411:34 amRNSForm 8.5 (EPT/RI) Pfizer Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.